Sierra Rizo Alejandro¹*, Moreno Gómez Eligio Rafael², Ruiz Castañeda Martin², Grageola Núñez Fernando³, Rosales Ramírez Rubén² and Mireles Flores Salvador²

¹Posgrado en Ecofisiología y Recursos Genéticos, Mexico
²Departamento de Producción Animal, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUCBA), Universidad de Guadalajara, Mexico
³Unidad Académica de Medicina Veterinariay Zootecnia, Universidad Autónoma de Nayarit, Mexico

*Corresponding Author: Mireles Flores Salvador, Posgrado en Ecofisiología y Recursos Genéticos, Mexico.

Received: December 04, 2023Published: February 11, 2024

Abstract

The extract mangosteen plant (Garcinia mangostana Lynn), with antibacterial capacity, was selected for its In vitro effect against frequent enterobacteria in the gastrointestinal tract (GIT) of living beings. In this work, the In vitro antibacterial activity was observed for enterobacteria and other selected ones (Escherichea coli, Staphylococcos aureus, Streptococcus spp., and Klebsiella pneumoniae). The value of the minimum inhibitory concentration (MIC) of the mangosteen extract, the supernatant, precipitate and dehydrated precipitate, commercial product XanGo®, xanthone 9-xanthene® and nanocellulose from Acacia farnesiana and the mixture between these phytobiotic compounds varied between 25 at 100% dilution and 5 to 10 mg/mL respectively. The results showed that there was a significant difference in the bacterial inhibition halos for enterobacteria (P < 0.05); The highest value (mm) was in XanGo® (20 ± 0.6), followed by mangosteen extract (16 ± 1.1), xanthone 9-xanthene® (7 ± 0.7) and nanocellulose (1 ± 0.1). For the Staphylococcus aureus group, the highest value recorded (mm) was XanGo® (20.13 ± 0.94), followed by mangosteen extract (16 ± 0.88), xanthone 9-xanthene® (7 ± 0.58) and nanocellulose (1 ± 0.33), so there are significant differences in the mixture between the phytobiotic compounds, where the highest achievement of inhibition was observed (11.3 ± 1.30), in the mixture of mangosteen extract and nanocellulose (1:1 dilution), with activity against Staphylococcus aureus strain 448. In the mixture of phytobiotic compounds, the highest achievement of inhibition for enterobacteria was observed (10.3 ± 0.2), with xanthone 9-xantene® and nanocellulose (1:1 dilution), for which is concluded in this study, the In vitro antibacterial activity of XanGo®, the mangosteen extract and xanthone 9-xanthene® is effective against enterobacteria, common pathogens of the digestive tract.

Keywords: Antibacterial; Enterobacteria; Mangosteen Extract, 9-Xanthene™

References

1. ABDULLAHI R., et al. “Preparation of Medicinal Plants: Basic Extraction and Fractionation Procedures for Experimental Purposes”. Journal of Pharmacy and Bioallied Sciences 1 (2020): 1-10.
2. ALAMGIR “Therapeutic use of medicinal plants and their extracts” 1 (2017).
3. “Official methods of analysis of International Assocition of Agricultural Chemicals; Contaminants: Drugs and Food Composition, Additives; Natural conteneirs, Washington, DC. The Scientific Association Dedicated to Analytical Excellence^® 16^th edition.
4. BADIALI C., et al. “Xanthones: Biosynthesis and Trafficking in Plants, Fungi and Lichens. Department of enviromental biology. Sapienza University or Rome. P. Le aldo Moro 5, 00185 Rome Italy”. Plants4 (2023): 694.
5. BUITENHUIS B., et al. “Análisis profundo de genes y mecanismos que involucran glándula mamaria y la patogénesis por Escherichia coli en la mastitis de Bovinos”. Biomed Central Genomics Ltd 12 (2011):130.
6. CHARALAMBOS K., et al. “Energing nanotechnology-based strategies for the identification of microbial pathogenesis”. Advanced Drug Delivery Reviews 62 (2010): 408-423.
7. CHENG G., et al. “Antibiotic alternatives: the substitution of antibiotics in animal husbandry?” Antimicrobials, Resistance and Chemotherapy 5 (2014).
8. DIAO Q., et al. “Review of strategies to promote rumen development in calves”. Animals (Basel) 8 (2019): 490.
9. DUBEY , et al. “Global promotion of herbal medicine: Indian´s opportunity”. Current Science 86 (2004): 37-41.
10. FAEHNRICH , et al. “Medicinal plants and their secondary metabolites state of the art and trends in breeding, analytics and use in feed supplementation with special focus on German”. Journal of Applied Botany and Food Quality Researchgate (2021).
11. GIBBONS S. “Plants as a source of bacterial resistance modulators and anti-infective agents”. Phytochemistry Reviews 4 (2005): 63-78.
12. GOTTLIEB OR., et al. “Integration of ethnobotany and phytochemistry: dream or reality?“ Phytochemistry 60 (2002): 145-152.
13. GOVINDACHARI KP., et al. “Xanthones of Garcinia Mangostana Linn”. Tetrahedron 27 (1971): 3919-3926.
14. HENG , et al. “Phytochemicals and antioxidant capacity of some tropical edible plants”. Asian Australiasian Journal of Animal (2018).
15. HENHE A., et al. “Effect of dietary Quebrancho tannin extract on feed intake, digestibility, excretion of urinary purine derivates and milk production in dairy cows”. Affiliations Expand (2017).
16. HUANG QX., et al. “Potential and challenges of tannins as an alternative to in-feed antibiotics for farm animal production” 2 (2018): 137-150.
17. JONG CB., et al. “Recent formulation approaches to oral delivery of herbal medicines”. Journal of Pharmaceutical Investigation 49 (2023): 17-26.
18. KASKE M., et al. “Recent Developments and perspectives in bovine Medicine. XXII world Buiatrics Congress”. Hannover Germany (2002).
19. KERTZ AF., et al. “A 100-year review: Calf nutrition and management 100.12 (2017): P10151-10172.
20. KIRK “Encyclopedia of Chemical Technology”. Vol 1-25 and supplement. Fourth edition. John Wiley and SONS (1998).
21. KMICIKEWYCZ AD. “Nutritional feeding and management strategies to optimize growth and heath in dairy calves”. A thesis The University of Minnesota (2011).
22. KRAUSS H., et al. “Zoonoses: infectious diseases transmissible from animals to humans, 3rd edition Wolfgang Preisercorresponding author”. Medical Microbiology and Immunology 4 (2005): 219-220.
23. MAGGINNI S., et al. “Inmune function and micronutrient requeriments change over the life course”. Nutrients 10 (2018): 1531.
24. MAHABUSARAKAM WP and Saowaluk P. “Antimicrobial activities of chemical constituents from Garcinia mangostana Linn”. Journal of The Science Society of Thailand 12 (1986): 239-242.
25. MAZID M., et al. “Role of secondary metabolites in defense mechanisms of plants”. Biology and Medicine 3 (2011): 232-249.
26. MENDENHALL W and Sincich T. “Probabilidad y estadística para ingeniería y ciencias. 4^th edition”. Prentice Hall (1997).
27. MOHANA DC., et al. “Antibacterial evaluation of some plants extracts against some human pathogenic bacteria”. Advances in Biological Research 2 (2008): 49-55.
28. NEWMAN , et al. “The influence of natural products upon drug Discovery”. Natural Product Research 17 (2000): 215-234.
29. OTHMAN Y and Tindall HD. “Mangosteen cultivation/Othman FAO plant production and protection division: Food and Agriculture Organization of the United Nations (1995):
30. PALAKAWONG C., et al. “Antioxidant and antimicrobial activities of crude extracts from mangosteen (Garcinia mangostana L.) parts and some essential oils”. International Food Research Journal 17 (2010): 583-589.
31. PERRI , et al. “Microbial life. Edit. SINAUER S. Massachusetts (2002).
32. PHONGPAICHIT S., et al. “Antibacterial activities of extracts from Garcinia mangostana pericarp on methicillin-resistant Sthaphylococcus aureus and enterococcus species”. SongklanaKarin Journal of Science and Technology 16 (1994): 399-405.
33. PONCE-PÉREZ. “Efecto de una formula poliherbal promotora de la función intestinal sobre parámetros productivos y salud en becerras Holstein”. RI- UAEMex. MX (2021).
34. RASKIN L., et al. “Plants and human health in the twenty-first Century”. Trends in Biotecnology 20 (2002): 522-531.
35. SALDIVAR SD. “Fitobióticos como alternativa para las enfermedades entéricas en animales“ (2019).
36. SALVIET “Synthesis and metabolism of phenolic compounds”. In De la Rosa L.A., P.E., Álvarez y A.G.A., González. (ed) Fruit and vegetable phytochemicals; Chemistry, Nutritional value and stability. Wiley- Blackwell Publishing New Delhi, India (2010): 89-100.
37. SALAHI B., et al. “Thymol, thyme and other plant sources health and potencial uses. Phytotherapy”. Wiley online library (2018).
38. SEEDI HRE., et al. “Metal nanoparticules fabricated by green chemistry using natural extracts biosynthesis, mechanism and apllications”. RSC Publication (2019).
39. SCHOGOR BAL., et al. “Calidad del calostro bovino y su relación con la genética, el manejo, la fisiología y su congelación”. Revista Córdoba1 (2020): 1465.
40. SIERRA RA. “Biomedicación con el extracto de mangostán y la xanthoma 9-xanthene para promover la microbiota benefica y aumentar el consume voluntario de alimento en becerras lactantes”. Universidad de Guadalajara. México (2015).
41. SORUM H and Abee-Lund TML. “Antibiotic resistance in food-related bacteria a result of interfering with the global web of bacterial genetics”. International Journal of Food Microbiology 78 (2002): 43-56.
42. SUNDARAM , et al. “Antimicrobial activities of Garcinia mangostana”. Plant Med 48 (1983): 59-60.
43. TANG YP., et al. “Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial”. Journal of Medicinal Food 12 (2009): 755-763.
44. PRIYA VV., et al. “Hepatoprotective natural products”. Research in Science and Technology 2 (23010): 49-52. ISSN: 2076- 5061.
45. VORAUTHIKUNCHAI A., et al. “Effective medicinal plants against enterohaemorrhagic Escherichia coli O157:H7”. Journal of Ethnopharmacology 94 (2004): 44-54.
46. WHITE DG., et al. “Antimicrobial resistance of foodborne pathogens”. Microbes and Infection 4 (2002): 405-
47. YEON KY., et al. “Discovery of gamma-mangostin from Garcinia mangostana as a potent and selective natural SIRT2 inhibitor”. Bioorganic Chemistry 94 (2020): 103403.
48. ZHUOHONG X., et al. “Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trial”. Food Science and Nutrition 4 (2015): 342-348.

Citation

Citation: Sierra Rizo Alejandro., et al.“In vitro Evaluation of Phytobiotics for the Inhibition of Common Enterobacteriaceae of the Gastrointestinal Tract".Acta Scientific Veterinary Sciences 6.3 (2024): 35-44.

Copyright

Copyright: © 2024 Mireles Flores Salvador., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.